The potential mechanism of Aidi injection against neuroblastoma-an investigation based on network pharmacology analysis
Background: Aidi injection, a classic traditional Chinese medicine (TCM) formula, has been used on a broader scale in treating a variety of cancers. In this study, we aimed to explore the potential anti-tumor effects of Aidi injection in the treatment of neuroblastoma (NB) using network pharmacology...
Saved in:
Main Authors: | Shuyang Dai (Author), Yaoyao Gu (Author), Yong Zhan (Author), Jie Zhang (Author), Lulu Xie (Author), Yi Li (Author), Yifei Lu (Author), Ran Yang (Author), Enqing Zhou (Author), Deqian Chen (Author), Songbin Liu (Author), Shan Zheng (Author), Zhaopeng Shi (Author), Kuiran Dong (Author), Rui Dong (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments
by: Haojia Wang, et al.
Published: (2023) -
Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression
by: Yuan Lu, et al.
Published: (2022) -
Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma
by: Yuan Lu, et al.
Published: (2021) -
Progress of oncolytic virotherapy for neuroblastoma
by: Xiao-Tong Chen, et al.
Published: (2022) -
Meta-Analysis of Aidi Injection and First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Treating Advanced Non-Small Cell Lung Cancer
by: Na Xiao MD, et al.
Published: (2021)